97 related articles for article (PubMed ID: 8518492)
21. Management of hypertension in patients with enhanced cardiovascular risk. Introduction.
White WB
Am J Med; 2008 Aug; 121(8 Suppl):S1. PubMed ID: 18638613
[No Abstract] [Full Text] [Related]
22. Safety and efficacy of moxonidine in mild to moderate hypertension.
Jain S; Malhotra P; Kumari S; Varma S
J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
[TBL] [Abstract][Full Text] [Related]
23. [Blood pressure reduction in hypertension--what is the optimal target value?].
Januszewicz W; Januszewicz A
Kardiol Pol; 2004 Nov; 61(11):505-10. PubMed ID: 15883611
[No Abstract] [Full Text] [Related]
24. [Acute phase of ischemic stroke. Reduce blood pressure--yes or no?].
Schunkert H
MMW Fortschr Med; 2008 May; 150(19):43-5. PubMed ID: 18589913
[No Abstract] [Full Text] [Related]
25. [Improving the control of systolic hypertension and pulse pressure in elderly population].
Sun N
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1441-2. PubMed ID: 12645505
[No Abstract] [Full Text] [Related]
26. Managing patients with high blood pressure before the introduction of antihypertensive drugs.
Roberts WC
Am J Cardiol; 2005 Nov; 96(10):1465-6. PubMed ID: 16275202
[No Abstract] [Full Text] [Related]
27. Lessons from recent hypertension trials: how low to lower blood pressure.
Gifford RW
South Med J; 2000 May; 93(5):528-30. PubMed ID: 10832958
[No Abstract] [Full Text] [Related]
28. Evaluation of endpoints in hypertension: blood pressure.
Meredith PA; Elliott HL
Blood Press Suppl; 1997; 2():86-90. PubMed ID: 9495634
[TBL] [Abstract][Full Text] [Related]
29. "Treating hypertension" or "lowering blood pressure"? Extending the concept.
Chalmers J
Blood Press; 2002; 11(2):68-70. PubMed ID: 12035873
[No Abstract] [Full Text] [Related]
30. [Vasoactive substances and long-term control of blood pressure and hypertension].
Takahashi H
Rinsho Byori; 1997 Sep; 45(9):813-21. PubMed ID: 9311253
[TBL] [Abstract][Full Text] [Related]
31. From the editor.
Weinberger MH
J Am Soc Hypertens; 2011; 5(6):433-4. PubMed ID: 22085745
[No Abstract] [Full Text] [Related]
32. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension.
Waeber B; Mourad JJ
Am J Hypertens; 2006 Sep; 19(9):985-6. PubMed ID: 16942945
[No Abstract] [Full Text] [Related]
33. Systolic hypertension.
Smith WM
Curr Ther Endocrinol Metab; 1997; 6():637-9. PubMed ID: 9174821
[No Abstract] [Full Text] [Related]
34. A review of hypertension in the elderly.
Alebiosu CO
Niger Postgrad Med J; 2001 Sep; 8(3):150-4. PubMed ID: 11721219
[TBL] [Abstract][Full Text] [Related]
35. The blood pressure measurement--revisited.
Safar ME; Smulyan H
Am Heart J; 2006 Sep; 152(3):417-9. PubMed ID: 16923406
[No Abstract] [Full Text] [Related]
36. Evaluation of hypertension control in Greek primary care units. The VANK study.
Skliros EA; Vasibossis A; Loumakis P; Sotiropoulos A; Giannakaki G; Razis N
J Hum Hypertens; 2003 Apr; 17(4):297-8. PubMed ID: 12692575
[No Abstract] [Full Text] [Related]
37. Association of blood pressure status with the optic disk structure.
Jonas JB
Am J Ophthalmol; 2006 Jul; 142(1):144-5. PubMed ID: 16815263
[No Abstract] [Full Text] [Related]
38. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
[No Abstract] [Full Text] [Related]
39. Chronotherapy beyond blood pressure reduction?
Simko F; Paulis L
J Pineal Res; 2008 Sep; 45(2):227-8. PubMed ID: 18318705
[No Abstract] [Full Text] [Related]
40. Do bone morphogenic protein-4 antagonists have any role in the treatment of human hypertension?
Yeter E; Kurt M; Ozçakar B; Denktaş AE
Anadolu Kardiyol Derg; 2009 Aug; 9(4):356-7. PubMed ID: 19666448
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
